Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 256-418-0 | CAS number: 49663-84-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 0.05 mg/m³
- Most sensitive endpoint:
- carcinogenicity
DNEL related information
- Explanation for the modification of the dose descriptor starting point:
In most European countries, the occupational exposure limits for Cr(VI) are set at 0.05 mg/m3 (see EU RAR Vol. 53, Table 4.1)
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- Explanation for the modification of the dose descriptor starting point:
Effects are considered to be covered by the Cr(VI) occupational limit (EU RAR Vol. 53)
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.04 mg/kg bw/day
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 170
- Dose descriptor starting point:
- NOAEL
- Value:
- 6.8 mg/kg bw/day
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 2
- AF for interspecies differences (allometric scaling):
- 2.5
- AF for other interspecies differences:
- 7
- AF for intraspecies differences:
- 5
- AF for the quality of the whole database:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.2 µg/cm²
- Most sensitive endpoint:
- sensitisation (skin)
DNEL related information
- Overall assessment factor (AF):
- 5
- Dose descriptor:
- other: NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
Inhalation DNEL / DMEL
Acute inhalation
In some exposure situations peak exposures may occur. Therefore a DNEL for acute toxicity might be needed. This can be derived by CrO3 datas, using the LC50 value of strontium chromate as a starting point. LC50 in the acute inhalation test with strontium chromate was 0.27-0.51 mg/l. When taking the worst case situation as a starting point, the value used was 0.27 mg/l = 270 mg/m3strontium chromate, which corresponds to 69 mg Cr(VI) /m3.
For the extrapolation of the LC50 to a NOAEC an assessment factor of 100 was used.
For intraspecies variation the assessment factor was 10 and for worker inter-individual variability the assessment factor was 5.
This results in a total assessment factor of 5,000.
The DNEL for acute inhalation would thus be 69 mg/m3/ 5,000 = 0.014 mg Cr(VI) /m3(=156 µg zinc tetraoxychromate/m3).
Long term inhalation / carcinogenicity
The genotoxicity of zinc tetraoxychromate as well as the evidence from epidemiologic dose-response data (Park and Stayner 2006) do not allow derivation of threshold doses. Consequently, derived no-effect levels (DNEL) for carcinogenicity of zinc tetraoxychromate cannot be set, and instead, a DMEL has to be derived.
The data from high-quality epidemiologic studies enables the possibility to quantitative risk assessment of Cr(VI). A lot of risk assessment activities on occupational hexavalent chromium exposures were carried out when the background documentation for U. S. OSHA was compiled (see, e.g., Park, Bena et al. 2004; OSHA 2006; Park and Stayner 2006). According to the assessments performed by OSHA, best estimates of lung cancer risks at an eight-hour averaged inhalation exposure level of 0.25 μg Cr(VI) /m3are 0.52–2.3 per 1,000 workers with a working lifetime of 45 years.
The 8-hour time-weighted occupational exposure limit in the (OSHA, based on epidemiological data) was adjusted to 5 μg/m3for Cr(VI) in 2006. This is also the current limit value inand. In other European countries the limit is higher. The level of 5 μg/m3is, however, clearly higher (10x10-3 – 45x10-3) than advised in REACH guidelines. For the great uncertainties rising from the extrapolations to lower exposure concentrations, but taking into account precautionary reasons, a DMEL of 0.5 μg Cr(VI) /m3is suggested for zinc tetraoxychromate.
The DMEL calculated for carcinogenicity is clearly lower than the acute inhalation DNEL. Based on this, the acute inhalation effects are considered to be covered by the very low inhalation DMEL derived for carcinogenicity. No DNEL is therefore proposed for acute inhalation.
In the registration dossier of insoluble and sparingly soluble zinc compounds, a DNEL of 5 mg/m3has been suggested for inhalation. As this value is much higher than the DMEL suggested for zinc tetraoxychromate, there is no need to take it into consideration in the risk characterisation.
Dermal DNEL
The DNEL for local dermal effects is based on skin sensitisation data. The DNEL calculations were performed according to appendix 8-10 of ECHA guidance R8, and the article of Basketter et al. (2003), which is included under "skin sensitisation", and which is also one of the references listed in appendix 8-10.
The starting point for the DNEL calculations was the results of a number of LLNA: s with potassium dichromate (Kimber et al. 2001). No such tests have been performed with zinc tetraoxychromate and therefore this report with data on a more soluble chromate was selected. This is likely to result in a very precautionary estimate on DNEL.
The EC3 (Effect Concentration 3; concentration that induces a stimulation index of 3 or more) for potassium dichromate was 0.058%, which means that the substance belongs to the category of substances with extreme potency (appendix R.8-10). The EC3 (%) can be converted to µg/cm2(ECHA guidance R8):
0.058*250=14.5 µg/cm2potassium dichromate, corresponding to 5.12 µg Cr/cm2
According to Basketter et al.(2003) this can be used as an NOEL. Chemicals with NOELs (derived from LLNA) ranging from 1 to 10 µg/cm2, have been grouped and a conservative NOEL of 1 µg/cm2should be suggested for this group (Basketter et al. 2003).
For the derivation of DNELs the following assessment factors were used:
- Intraspecies variation: 1 (LLNA data correlates very well with human data, Basketter et al. 2003)
- Inter-individual variability: 5 (workers)
- Matrix effect: 1 (Dermal exposure to zinc tetraoxychromate occurs for example via spraying paint. For this matrix an assessment factor might be needed. However, no AF was used in order to compensate for the the situation that zinc tetraoxychromate is much less soluble (~1 g/l) than potassium chromate (~115 g/l) which was used in the LLNA. Due to the low solubility of zinc tetraoxychromate, its skin penetration, and therefore its sensitisation potential, is likely to be much lower than that of soluble chromates like potassium dichromate.
- Use pattern: 1 (Basketter et al. 2003 used an AF of 3 for the use pattern when calculating acceptable exposure levels for consumer products. However, in the case of zinc tetraoxychromate, the exposure is unintentional and occurs only for very brief periods of time.
Based on the above mentioned NOEL and assessment factor (5), the DNEL for zinc tetraoxychromate can be calculated as 1 µg/cm2/ 5 = 0.2 µg/cm2as Cr(VI) (= 2.2 µg/cm2as zinc tetraoxychromate).
As a comparison, it can be mentioned that the minimal eliciting threshold (MET)10% concentration for chromium allergic patients patch tested with potassium dichromate was 0.03 µg Cr(VI) /cm2/48 hours (Hansen et al. 2003), corresponding to 0.72 µg/cm2/2 hours of exposure (as Cr(VI)).
In appendix 8-10 of ECHA guidance R8, it is stated that 'it is not appropriate to define elicitation thresholds as a function of skin sensitising potency' and the derivation of DNELs for skin sensitisers in the guidance is thus focused only on the induction phase. Accordingly, the DNEL suggested for dermal exposure to zinc tetraoxychromate is based on the LLNA data.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Additional information - General Population
The general population is not exposed to zinc tetraoxychromate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.